Hide pageGet help now
Whether you are someone with experience of mental health problems or psychosis, a relative or friend, there are lots of ways in which you can get involved in projects related to mental health and well-being. Some opportunities will be voluntary; some will be paid.
Writing in book illustration

If you select your location below, you will some of the research studies and other events in your local area. You can ask your care co-ordinator or EYE-2 Research Assistant for more information and more opportunities locally. All the studies and news events are written by the people who are running them.

Localised news and events

Hampshire Research Studies

DFEND

DFEND is a randomised, double blind, placebo controlled parallel group trial of vitamin D supplementation compared to placebo in people presenting with their first episode of psychosis.

This study aims to explore how the addition of vitamin D supplements to standard treatments can help people recover after having their first episode of psychosis.

What is involved?

Participants of the study will continue to receive their standard treatments for psychosis. Half of the participants will be randomly allocated to receive a vitamin D supplement while the other half will receive a placebo treatment. Treatment will last for 6 months with 6 monthly home visits.

Interested?

To take part in this study you must meet the following criteria:

Aged 18-45 years old; Diagnosis of psychosis; Willing to refrain from taking multivitamins or non-study vitamin d supplements including cod liver oil.

You cannot take part in this study if:

You have a known intolerance of vitamin D2 or D3 or known allergy to any of the trial medicine; You are currently taking vitamin D supplements at a dose exceeding 400IU/day; You have a known current anaemia, sickle cell anaemia and beta or alpha thalassemia.

If you would like to take part of want more information please contact the study lead:

Joanne McCarthy; Email: joanne.mccarthy@nhs.net; Tel: 02380 475943


HWB – Lifestyle, Health and Wellbeing Survey

Lifestyle, Health and Wellbeing Survey logo

The aim of this survey is to provide information about the health and wellbeing of people with Severe Mental Illness. The two main objectives are: to benchmark current health related behaviours for people with severe mental ill health; and to provide a platform for future research with this population.

What is involved?

You will be asked to complete a short survey, which will take approximately 5 minutes to complete. You can then post this in a free post envelope back to the University of York research team.

Interested?

To take part you must meet the following criteria:

Aged 18 or over; Have a recorded diagnosis of a serious mental illness (SMI) including schizophrenia, schizoaffective disorder, bipolar affective disorder, and associated disorders.

Unfortunately you cannot take part if:

You are a non-English speaker; Lack the mental capacity to give consent to participating.

If you would like to take part or want more information please contact the study lead:

Erica Bethell; Email: Erica.bethell@southernhealth.nhs.uk; Tel: 02380 475948


L.O.S.E Weight

L.O.S.E.Weight – Liraglutide and the management of Overweight and obesity in people with Schizophrenia: a pilot study.

This study will look at the use of a weight loss drug in people with severe mental illness. This is a pilot study to gather data on recruitment, consent, retention, adherence and dropout rates.

What is involved?

Participants will be randomised to either taking the study drug (Max dose 3mg daily) or a placebo for 6 months.

Interested?

To take part you must meet the following criteria:

Have a diagnosis of Schizophrenia, Schzio-affective Disorder or First Episode Psychosis.; Aged between 18-75 years; Treatment with an antipsychotic medication for a minimum of one month; Be either obese or overweight with at least one weight related consequence such as hypertendion; Ability and willingness to take the study drug (liraglutide) or placebo.

Unfortunately you cannot take part if:

You’re pregnant or have a desire to become pregnant.

If you would like to take part or want more information please contact the study lead:

Clare Whicher; Email: Clare.whicher@nhs.net; Tel: 02830 475258


AppRoVE

AppRoVE – Assertive Responding to Voices: Evaluating the psychotic properties of new measures of responding to distressing voices and other people.

This study aims to evaluate the psychometric properties of two new measures of assertive responding to: 1) distressing voices (auditory hallucinations) and 2) other people.

What is involved?

Completing a questionnaire booklet which contains 6 questionnaires, 150 questions in total.

Interested?

To take part you must meet the following criteria:

Aged 18 and over; Any service user with mental health problems who has been hearing voices for at least 6 months.

Unfortunately you cannot take part if:

You do not speak English

If you would like to take part or want more information please contact the study lead:

Danielle McCracken; Email: Danielle.McCracken1@nhs.net; Tel: 02380 475943



COPe – Carers fOr people with Psychosis E-support

COPE Support logo

E-support for families and friends of individuals affected by Psychosis. The study aims to find out if COPe-support works to improve carers’ wellbeing and how well they cope with caring. The COPe-support provides peer support, information on psychosis and ways for carers to look after themselves, all online.

What is involved?

We are inviting carers supporting a loved one affected by psychosis to join the study, using the online resource called COPe. Carers can be parents, partners, siblings, other relatives or close friends. Participants will receive £30 in total for their time.

Interested?

To take part you must meet the following criteria:

Supporting a loved one affected by Psychosis; Aged 18+Have internet access

Unfortunately you cannot take part if:

You’re not living in England; Unable to communicate in English

If you would like to take part or want more information please contact the study lead:

Carolyn Asher; Email: c.asher@nhs.net; Tel: 02382 310787 or 02380 475943